About Us
TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing sterile bone allografts.
We are currently helping to transform the treatment of patients in key surgical applications: BioSurgery, Orthopaedics (sports medicine/spine), Dental, General, Plastic Surgery, Urology/Gynaecology, Ophthalmology, and Cardiac.
Our Vision
Establish TRG as a leader in regenerative medicine science and innovation.
Transform patient care and deliver favorable health economic outcomes.
Product Portfolio
Bone (BioRinse®)
- Flagship: ConCelltrate®
- Applications: Spine, Foot/Ankle, Dental, Orthopaedics
- Differentiators: Verified osteoinductivity, superior handling, reduced flush out
Soft Tissue (dCELL®)
- Flagship: DermaPure®
- Applications: Urogynaecology, Sports Medicine, Open Wound, Plastics
- Differentiators: Gentle, soft tissue decellularization process, removes DNA and cellular material to reduce the risk of rejection.
Soft Tissue (dCELL®)
- Flagship: OrthoPure® XT *
- Applications: Sports Medicine
- Differentiators: Biocompatible xenograft provides biomechanically appropriate tissue scaffold for cellular repopulation and eventual regeneration. Good clinical outcomes, no second graft site required, room temperature storage, good handling properties.
* Not available in the US
Birth Tissue
- Flagship: AmnioWorks™
- Applications: Ophthalmology, Wound Covering
- Differentiators: Clinical outcomes, barrier for faster healing, room temperature storage
